Alprazolam Significantly Improves the Efficacy of Granisetron in the Prophylaxis of Emesis Secondary to Moderately Emetogenic Chemotherapy in Patients with Breast Cancer

Publisher： Karger

E-ISSN： 1421-9794|51|5|280-285

ISSN： 0009-3157

Source： Chemotherapy, Vol.51, Iss.5, 2005-08, pp. : 280-285

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Double-Blind, Crossover, Randomized Comparison of Granisetron and Ramosetron for the Prevention of Acute and Delayed Cisplatin-Induced Emesis in Patients with Gastrointestinal Cancer: Is Patient Preference a Better Primary Endpoint?

By  

Chemotherapy, Vol. 49, Iss. 6, 2003-12 ,pp. : 316-323

Karger

Access to resources Recommend Favorite

Efficacy of Adjuvant Chemotherapy and Prognostic Factors for Patients with Extrahepatic Bile Duct Cancer

By  

Chemotherapy, Vol. 61, Iss. 3, 2016-01 ,pp. : 152-158

Karger

Access to resources Recommend Favorite

The Glasgow Prognostic Score Predicts Response to Chemotherapy in Patients with Metastatic Breast Cancer

By  

Chemotherapy, Vol. 61, Iss. 4, 2016-02 ,pp. : 217-222

Karger

Access to resources Recommend Favorite

Second-Line Combination Chemotherapy with Vinorelbine and Capecitabine in Patients with Advanced Breast Cancer Previously Treated with Anthracyclines and/or Taxanes

By  

Chemotherapy, Vol. 57, Iss. 1, 2011-02 ,pp. : 71-76

Karger

Access to resources Recommend Favorite

Can Zoledronic Acid be Beneficial for Promoting Tumor Response in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy?

By Charehbili Ayoub   Fontein Duveken B. Y.   Kroep Judith R.   Liefers Gerrit-Jan   Nortier Johannes W. R.   van de Velde Cornelis J. H.  

Journal of Clinical Medicine, Vol. 2, Iss. 4, 2013-10 ,pp. : 188-200

MDPI

Access to resources Recommend Favorite